Brain Tumor Working Group Report on the 9th International Conference on Brain Tumor Research and Therapy. Organ System Program, National Cancer Institute.
Deen
D F
DF
University of California, San Francisco.
Chiarodo
A
A
Grimm
E A
EA
Fike
J R
JR
Israel
M A
MA
Kun
L E
LE
Levin
V A
VA
Marton
L J
LJ
Packer
R J
RJ
Pegg
A E
AE
D000328:Adult; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000235:genetics / Q000401:mortality / Q000473:pathology / Q000628:therapy; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D000518:Eflornithine / Q000627:therapeutic use; D005544:Forecasting; D006133:Growth Substances / Q000235:genetics; D006801:Humans; D016219:Immunotherapy, Adoptive; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D008527:Medulloblastoma / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy; D008577:Meningeal Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy; D051379:Mice; D009361:Neoplasm Invasiveness; D011073:Polyamines / Q000378:metabolism; D011519:Proto-Oncogenes; D011878:Radiotherapy / Q000009:adverse effects / Q000379:methods; D016019:Survival Analysis; D016896:Treatment Outcome; D014407:Tumor Cells, Cultured
D000970:Antineoplastic Agents; D006133:Growth Substances; D007457:Iodine Radioisotopes; D011073:Polyamines; D000518:Eflornithine